September 2025 Price Concessions 2nd Update
The Department of Health and Social Care (DHSC) has today (23/09/2025) confirmed the following list of price concessions for September 2025:
| Drug | Pack size | Price concession |
| Amiodarone 200mg tablets | 28 | £5.97 |
| Co-careldopa 25mg/100mg tablets | 100 | £8.38 |
| Co-codamol 30mg/500mg tablets | 30 | £1.23 |
| Co-codamol 30mg/500mg tablets | 100 | £4.10 |
| Esomeprazole 20mg gastro-resistant capsules | 28 | £4.95 |
| Fenofibrate micronised 267mg capsules | 28 | £5.80 |
| Fexofenadine 180mg tablets | 30 | £5.00 |
| Ibandronic acid 150mg tablets | 1 | £2.95 |
| Indapamide 2.5mg tablets | 28 | £6.98 |
| Latanoprost 50micrograms/ml eye drops | 2.5 | £1.81 |
| Oxybutynin 5mg tablets | 56 | £3.67 |
| Propranolol 80mg modified-release capsules | 28 | £5.94 |
| Repaglinide 1mg tablets | 90 | £11.17 |
| Sitagliptin 100mg tablets | 28 | £2.84 |
| Sitagliptin 100mg/5ml oral solution sugar free | 150 | £21.63 |
For the full list of price concessions granted for September 2025 so far please visit our price concession hub page here.
There are no prices that rolled over from the previous month.
Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
Notes
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Next Steps
Pharmacies should continue to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on our website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, submit further price concession applications to DHSC. Any prices granted by DHSC, will only be agreed by Community Pharmacy England if they are supported by the reports received by our team.
Top-up payments will be made for certain products if data from the Margin Survey identifies that the original concession prices granted by DHSC were inappropriately low compared to the average pharmacy purchase price for the month. In such cases, a top-up will be triggered automatically and paid on a quarterly basis. More information on retrospective top-ups can be found here.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions)
